Literature DB >> 18936167

New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.

Catherine Chabot1, Kathleen Spring, Jean-Philippe Gratton, Mounib Elchebly, Isabelle Royal.   

Abstract

Functional inactivation of the protein tyrosine phosphatase DEP-1 leads to increased endothelial cell proliferation and failure of vessels to remodel and branch. DEP-1 has also been proposed to contribute to the contact inhibition of endothelial cell growth via dephosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), a mediator of vascular development. However, how DEP-1 regulates VEGF-dependent signaling and biological responses remains ill-defined. We show here that DEP-1 targets tyrosine residues in the VEGFR2 kinase activation loop. Consequently, depletion of DEP-1 results in the increased phosphorylation of all major VEGFR2 autophosphorylation sites, but surprisingly, not in the overall stimulation of VEGF-dependent signaling. The increased phosphorylation of Src on Y529 under these conditions results in impaired Src and Akt activation. This inhibition is similarly observed upon expression of catalytically inactive DEP-1, and coexpression of an active Src-Y529F mutant rescues Akt activation. Reduced Src activity correlates with decreased phosphorylation of Gab1, an adapter protein involved in VEGF-dependent Akt activation. Hypophosphorylated Gab1 is unable to fully associate with phosphatidylinositol 3-kinase, VEGFR2, and VE-cadherin complexes, leading to suboptimal Akt activation and increased cell death. Overall, our results reveal that despite its negative role on global VEGFR2 phosphorylation, DEP-1 is a positive regulator of VEGF-mediated Src and Akt activation and endothelial cell survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936167      PMCID: PMC2612487          DOI: 10.1128/MCB.01374-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

Review 1.  Role of angiogenesis in cardiovascular disease: a critical appraisal.

Authors:  Rohit Khurana; Michael Simons; John F Martin; Ian C Zachary
Journal:  Circulation       Date:  2005-09-20       Impact factor: 29.690

2.  Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta.

Authors:  H Honda; J Inazawa; J Nishida; Y Yazaki; H Hirai
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

3.  A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.

Authors:  Takamune Takahashi; Keiko Takahashi; Patricia L St John; Paul A Fleming; Takuya Tomemori; Toshio Watanabe; Dale R Abrahamson; Christopher J Drake; Takuji Shirasawa; Thomas O Daniel
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo.

Authors:  Juhua Chen; Payaningal R Somanath; Olga Razorenova; William S Chen; Nissim Hay; Paul Bornstein; Tatiana V Byzova
Journal:  Nat Med       Date:  2005-10-16       Impact factor: 53.440

5.  Control of adhesion-dependent cell survival by focal adhesion kinase.

Authors:  S M Frisch; K Vuori; E Ruoslahti; P Y Chan-Hui
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

Authors:  D Guo; Q Jia; H Y Song; R S Warren; D B Donner
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

8.  Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density.

Authors:  A Ostman; Q Yang; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.

Authors:  Maria Grazia Lampugnani; Adriana Zanetti; Monica Corada; Takamune Takahashi; Giovanna Balconi; Ferruccio Breviario; Fabrizio Orsenigo; Anna Cattelino; Rolf Kemler; Thomas O Daniel; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

View more
  39 in total

1.  Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Authors:  Keiko Takahashi; Raymond L Mernaugh; David B Friedman; Rebecca Weller; Nobuo Tsuboi; Hironobu Yamashita; Vito Quaranta; Takamune Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

2.  Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

3.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

4.  Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.

Authors:  Lei Nie; Xiaojia Guo; Leila Esmailzadeh; Jiasheng Zhang; Abolfazl Asadi; Mark Collinge; Xuan Li; Jun-Dae Kim; Melissa Woolls; Suk-Won Jin; Alexandre Dubrac; Anne Eichmann; Michael Simons; Jeffrey R Bender; Mehran M Sadeghi
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

5.  Receptor protein tyrosine phosphatase-receptor tyrosine kinase substrate screen identifies EphA2 as a target for LAR in cell migration.

Authors:  Hojin Lee; Anton M Bennett
Journal:  Mol Cell Biol       Date:  2013-01-28       Impact factor: 4.272

6.  Vascular endothelial growth factor receptor-2 activates ADP-ribosylation factor 1 to promote endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells.

Authors:  Zeinab Daher; Pierre-Luc Boulay; Fanny Desjardins; Jean-Philippe Gratton; Audrey Claing
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

7.  VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis.

Authors:  Anthony A Lanahan; Karlien Hermans; Filip Claes; Joanna S Kerley-Hamilton; Zhen W Zhuang; Frank J Giordano; Peter Carmeliet; Michael Simons
Journal:  Dev Cell       Date:  2010-05-06       Impact factor: 12.270

Review 8.  Phosphatase regulation of intercellular junctions.

Authors:  Declan F McCole
Journal:  Tissue Barriers       Date:  2013-10-10

Review 9.  Modulation of VEGF receptor 2 signaling by protein phosphatases.

Authors:  Federico Corti; Michael Simons
Journal:  Pharmacol Res       Date:  2016-11-23       Impact factor: 7.658

10.  Identification of receptor protein tyrosine phosphatases (RPTPs) as regulators of receptor tyrosine kinases (RTKs) using an RPTP siRNA-RTK substrate screen.

Authors:  Hojin Lee; Anton M Bennett
Journal:  Methods Mol Biol       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.